373 related articles for article (PubMed ID: 23539216)
1. Tissue characterization after drug-eluting stent implantation using optical coherence tomography.
Malle C; Tada T; Steigerwald K; Ughi GJ; Schuster T; Nakano M; Massberg S; Jehle J; Guagliumi G; Kastrati A; Virmani R; Byrne RA; Joner M
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1376-83. PubMed ID: 23539216
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
3. Difference in neointimal appearance between early and late restenosis after sirolimus-eluting stent implantation assessed by optical coherence tomography.
Ino Y; Kubo T; Kitabata H; Ishibashi K; Tanimoto T; Matsuo Y; Shimamura K; Shiono Y; Orii M; Komukai K; Yamano T; Yamaguchi T; Hirata K; Tanaka A; Mizukoshi M; Imanishi T; Akasaka T
Coron Artery Dis; 2013 Mar; 24(2):95-101. PubMed ID: 23363984
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo assessment of neointimal characteristics after drug-eluting stent implantation: Optical coherence tomography and histopathology validation study.
Imanaka T; Fujii K; Hao H; Shibuya M; Saita T; Kawakami R; Fukunaga M; Kawai K; Tamaru H; Miki K; Horimatsu T; Sumiyoshi A; Nishimura M; Hirota S; Masuyama T; Ishihara M
Int J Cardiol; 2016 Oct; 221():1043-7. PubMed ID: 27447812
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
[TBL] [Abstract][Full Text] [Related]
6. Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: optical coherence tomographic analysis.
Tanaka N; Terashima M; Rathore S; Itoh T; Habara M; Nasu K; Kimura M; Itoh T; Kinoshita Y; Ehara M; Tsuchikane E; Asakura K; Asakura Y; Katoh O; Suzuki T
JACC Cardiovasc Interv; 2010 Oct; 3(10):1074-9. PubMed ID: 20965467
[TBL] [Abstract][Full Text] [Related]
7. Two-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Endeavor zotarolimus-eluting stent.
Nishinari M; Shimohama T; Tojo T; Shiono T; Shinagawa H; Kameda R; Aoyama N; Izumi T
Catheter Cardiovasc Interv; 2013 Dec; 82(7):E871-8. PubMed ID: 23873677
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence evaluation of everolimus-eluting stents 8 months after implantation.
Inoue T; Shite J; Yoon J; Shinke T; Otake H; Sawada T; Kawamori H; Katoh H; Miyoshi N; Yoshino N; Kozuki A; Hariki H; Hirata K
Heart; 2011 Sep; 97(17):1379-84. PubMed ID: 21051456
[TBL] [Abstract][Full Text] [Related]
9. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.
Davlouros PA; Nikokiris G; Karantalis V; Mavronasiou E; Xanthopoulou I; Damelou A; Tsigkas G; Alexopoulos D
Int J Cardiol; 2011 Sep; 151(2):155-9. PubMed ID: 20605242
[TBL] [Abstract][Full Text] [Related]
10. [Visualization of intimal proliferation of drug-eluting stent and bare mental stent by use of optical coherence tomography].
Chen BX; Ma FY; Luo W; Xie WL; Sun SH; Guo XM; Wang F; Zhao XZ; Chu XW
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1102-6. PubMed ID: 16796834
[TBL] [Abstract][Full Text] [Related]
11. Histological validation of frequency domain optical coherence tomography for the evaluation of neointimal formation after a novel polymer-free sirolimus-eluting stent implantation.
Fu Q; Hu H; Chen W; Tan Z; Li L; Wang D; Chen B
Int J Clin Exp Pathol; 2015; 8(9):11068-75. PubMed ID: 26617825
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of below-the-knee drug-eluting stents with frequency-domain optical coherence tomography: neointimal hyperplasia and neoatherosclerosis.
Paraskevopoulos I; Spiliopoulos S; Davlouros P; Karnabatidis D; Katsanos K; Alexopoulos D; Siablis D
J Endovasc Ther; 2013 Feb; 20(1):80-93. PubMed ID: 23391087
[TBL] [Abstract][Full Text] [Related]
13. Morphological and quantitative analysis of vascular wall and neointimal hyperplasia after coronary stenting: comparison of bare-metal and sirolimus-eluting stents using optical coherence tomography.
Goto I; Itoh T; Kimura T; Fusazaki T; Matsui H; Sugawara S; Komuro K; Nakamura M
Circ J; 2011; 75(7):1633-40. PubMed ID: 21628836
[TBL] [Abstract][Full Text] [Related]
14. Novel neointimal formation over sirolimus-eluting stents identified by coronary angioscopy and optical coherence tomography.
Murakami D; Takano M; Yamamoto M; Inami S; Ohba T; Seino Y; Mizuno K
J Cardiol; 2009 Apr; 53(2):311-3. PubMed ID: 19304139
[TBL] [Abstract][Full Text] [Related]
15. Early vascular healing with biodegradable polymer coated sirolimus-eluting coronary stent implantation: assessed by optical coherence tomography results at 4-month follow-up.
Abhyankar A; Prajapati J; Reddy S; Reddy S
Minerva Cardioangiol; 2013 Jun; 61(3):313-22. PubMed ID: 23681134
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic validation of optical coherence tomography findings of non-apposed side-branch struts in porcine arteries.
Her AY; Kim JS; Kim YH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
J Invasive Cardiol; 2013 Jul; 25(7):364-6. PubMed ID: 23813068
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation.
Murata A; Wallace-Bradley D; Tellez A; Alviar C; Aboodi M; Sheehy A; Coleman L; Perkins L; Nakazawa G; Mintz G; Kaluza GL; Virmani R; Granada JF
JACC Cardiovasc Imaging; 2010 Jan; 3(1):76-84. PubMed ID: 20129535
[TBL] [Abstract][Full Text] [Related]
18. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography.
Yao ZH; Matsubara T; Inada T; Suzuki Y; Suzuki T
Chin Med J (Engl); 2008 Mar; 121(6):503-7. PubMed ID: 18364133
[TBL] [Abstract][Full Text] [Related]
19. Serial Optical Coherence Tomography Evaluation at 6, 12, and 24 Months After Biolimus A9-Eluting Biodegradable Polymer-Coated Stent Implantation.
Konishi A; Shinke T; Otake H; Takaya T; Osue T; Kinutani H; Kuroda M; Takahashi H; Terashita D; Shite J; Hirata K
Can J Cardiol; 2015 Aug; 31(8):980-8. PubMed ID: 26117623
[TBL] [Abstract][Full Text] [Related]
20. Peri-strut low-intensity areas in optical coherence tomography correlate with peri-strut inflammation and neointimal proliferation: an in-vivo correlation study in the familial hypercholesterolemic coronary swine model of in-stent restenosis.
Tellez A; Afari ME; Buszman PP; Seifert P; Cheng Y; Milewski K; McGregor JC; Garza JA; Roberts MB; Yi GH; Kaluza GL; Granada JF
Coron Artery Dis; 2014 Nov; 25(7):595-601. PubMed ID: 25013949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
